UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024630
Receipt number R000028335
Scientific Title Study of oral health control and probiotics in the elderly people
Date of disclosure of the study information 2016/11/03
Last modified on 2019/02/26 09:17:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of oral health control and probiotics in the elderly people

Acronym

Oral health and probiotics

Scientific Title

Study of oral health control and probiotics in the elderly people

Scientific Title:Acronym

Oral health and probiotics

Region

Japan


Condition

Condition

healthy elderly people

Classification by specialty

Dental medicine Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The aim is to assess the effect of lactic acid bacteria-containing tablets on oral health control.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change of oral health condition by the oral administration of lactic acid bacteria-containing tablets for 2 months: Plaque index, tongue coating, probing pocket depth, bleeding on probing, volatile sulfur compound.

Key secondary outcomes

composition of oral microbiota


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The subjects ingest the tablets containing Lactobacillus salivarius WB21 for 2 months. The dose throughout the test period is maintained at 1 tablet 3 times per day (2.0 x 10^9 colony forming units per day), taken orally after eating and mouth cleaning.

Interventions/Control_2

The subjects ingest the placebo tablets for 2 months. The dose throughout the test period is maintained at 1 tablet 3 times per day, taken orally after eating and mouth cleaning. The placebo tablets are same composition except for L. salivarius WB21.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy elderly people

Key exclusion criteria

not wearing complete denture prostheses, not currently visiting a dentist for treatment, not using antibiotics within 3 months, having no smoking habit, having no adverse reactions to lactose or fermented milk products, having no serious metabolic disorders, having no cancer

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Hirofuji

Organization

Fukuoka Dental College

Division name

Department of General Dentistry

Zip code


Address

2-15-1, Tamura Sawara-ku, Fukuoka, Japan

TEL

81-91-801-0411

Email

hirofuji@college.fdcnet.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nao Taniguchi

Organization

Fukuoka Dental College

Division name

Department of Preventive and Public Health Dentistry

Zip code


Address

2-15-1, Tamura Sawara-ku, Fukuoka, Japan

TEL

81-91-801-0411

Homepage URL


Email

naojsz@college.fdcnet.ac.jp


Sponsor or person

Institute

Fukuoka Dental College

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑紫南コミュニティセンター(福岡県)


Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 03 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 29 Day

Last modified on

2019 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028335


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name